First Horizon Advisors, Inc. Abbott Laboratories Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 117,119 shares of ABT stock, worth $14.6 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

117,119

Previous 114,754 2.06%

Holding current value

$14.6 Million

Previous $11.9 Million 11.98%

% of portfolio

0.37%

Previous 0.36%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $236,665 - $279,377	2,365 Added 2.06%	117,119 $13.4 Million
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $400,603 - $447,173	-3,977 Reduced 3.35%	114,754 $11.9 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $99,882 - $110,315	-912 Reduced 0.76%	118,731 $13.5 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $328,562 - $402,187	-3,643 Reduced 2.95%	119,643 $13.2 Million
Q3 2023 Oct 27, 2023	BUY	$95.53 - $114.62 $130,493 - $156,570	1,366 Added 1.12%	123,286 $11.9 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $81,027 - $90,281	-804 Reduced 0.66%	121,920 $13.3 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $842,778 - $992,001	8,701 Added 7.63%	122,724 $12.4 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $258,182 - $302,888	-2,716 Reduced 2.33%	114,023 $12.5 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $254,962 - $295,199	-2,635 Reduced 2.21%	116,739 $11.3 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $1.13 Million - $1.37 Million	11,079 Added 10.23%	119,374 $13 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $3 Million - $3.66 Million	-26,288 Reduced 19.53%	108,295 $12.8 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $64,812 - $79,359	-561 Reduced 0.42%	134,583 $18.9 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $298,299 - $330,006	2,557 Added 1.93%	135,144 $16 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $11.9 Million - $13.1 Million	101,713 Added 329.45%	132,587 $15.7 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $1,904 - $2,241	-18 Reduced 0.06%	30,874 $3.58 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $121,247 - $142,848	-1,114 Reduced 3.48%	30,892 $3.7 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $106,890 - $116,479	-1,018 Reduced 3.08%	32,006 $3.5 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $17,045 - $20,699	-186 Reduced 0.56%	33,024 $3.59 Million
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $57,580 - $73,696	-752 Reduced 2.21%	33,210 $3.04 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $59,490 - $86,991	-947 Reduced 2.71%	33,962 $2.68 Million
Q4 2019 Jan 07, 2020	SELL	$78.51 - $87.4 $5,181 - $5,768	-66 Reduced 0.19%	34,909 $3.03 Million
Q3 2019 Oct 23, 2019	SELL	$81.84 - $88.74 $130,207 - $141,185	-1,591 Reduced 4.35%	34,975 $2.93 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $162,813 - $189,890	-2,234 Reduced 5.76%	36,566 $0
Q1 2019 Apr 26, 2019	SELL	$66.22 - $80.06 $200,050 - $241,861	-3,021 Reduced 7.22%	38,800 $0
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $214,577 - $243,085	-3,273 Reduced 7.26%	41,821 $3.02 Million
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $2.51 Million - $3.02 Million	41,218 Added 1063.42%	45,094 $0
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $2.62 Million - $3.17 Million	-43,160 Reduced 91.76%	3,876 $0
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $1.47 Million - $1.62 Million	25,572 Added 119.14%	47,036 $0
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $133,978 - $151,479	-2,381 Reduced 9.99%	21,464 $0
Q4 2017 Jan 25, 2018	BUY	$53.68 - $57.47 $80,305 - $85,975	1,496 Added 6.69%	23,845 $0
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $16,772 - $18,720	349 Added 1.59%	22,349 $0
Q2 2017 Aug 14, 2017	BUY	N/A	22,000	22,000 $0

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Abbott Laboratories Transaction History